ArticleObesity surgery2025
The Mid-term Efficacy of Sleeve-Nissen Versus Sleeve-Toupet Fundoplication for the Management of Gastroesophageal Reflux Disease in Patients with Obesity.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Crural Repair with or without Fundoplication During Sleeve Gastrectomy for Hiatal Hernia: Reflux Recurrence and Intrathoracic Migration at 18 Months.Obesity surgery · 2026Article
- Efficacy and Safety of Fundoplication Sleeve Gastrectomy in Obesity and GERD: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSleeve gastrectomy with fundoplication is emerging as a new surgical option for obesity with gastroesophageal reflux disease (GERD). However, comparative data on different fundoplication techniques combined with sleeve gastrectomy are limited.
objectivesTo compare the mid-term efficacy of sleeve gastrectomy with Nissen fundoplication (SGNF) versus sleeve gastrectomy with Toupet fundoplication (SGTF) in patients affected by obesity with GERD.
methodsThis retrospective study enrolled 54 patients affected by obesity with GERD who underwent SGNF or SGTF between January 2019 and November 2023.
resultsOf 54 initially enrolled patients, 3 were lost to follow-up. The remaining 51 were analyzed: 24 underwent SGNF and 27 underwent SGTF. Postoperative hospital stay was significantly longer in the SGNF group (5.5 [4, 7] days), compared to the SGTF group (4 [3, 5] days) (P = 0.002). At 3-5 years after surgery, mean %TWL was 25.77 ± 7.71% in the SGNF group and 28.16 ± 10.59% in the SGTF group (P = 0.475). Remission of GERD was seen in 75.0% (SGNF) and 72.7% (SGTF) of patients (P = 0.846); both groups showed a significant decrease in GERD-Q scores from baseline (P < 0.001). Endoscopic follow-up demonstrated esophagitis decreased from 23.5% preoperatively to 8.0% postoperatively in the combined cohort.
conclusionsSGNF and SGTF were shown to be a safe and effective intervention with comparative outcomes at mid-term follow-up. A prospective randomized clinical trial with longer follow-up is needed to elucidate the long-term outcomes.
Indexed as
Identifiers
40782274What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.